Kerendia 10mg Tablet is used to slow the progression of kidney damage in patients with chronic kidney disease (CKD) associated with type 2 diabetes. It is a specialised kidney-protective medicine that significantly reduces the risk of heart failure, kidney failure, and cardiovascular death. By protecting both the heart and kidneys simultaneously, it helps manage the complications commonly seen in patients with diabetes.
The active ingredient, finerenone, works by blocking the overactivation of the mineralocorticoid receptor (MR), which can contribute to inflammation and damage in the heart and kidneys. By reducing this overactivity, the medicine helps slow the decline in estimated glomerular filtration rate (eGFR) and lowers the risk of end-stage kidney disease. It represents an important advancement in the long-term management of diabetes-related kidney complications.
Consult your doctor regarding the appropriate dose based on your kidney function and electrolyte levels. Regular monitoring of potassium levels may be required during treatment with this medicine. To ensure safe and effective treatment, inform your healthcare provider about any pre-existing heart disease or other medicines you are taking.

















































































